Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study-Reference-Cited by-同舟云学术

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

Published:2011-03 Issue:3 Volume:12 Page:245-255
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cuzick Jack,Swanson Gregory P,Fisher Gabrielle,Brothman Arthur R,Berney Daniel M,Reid Julia E,Mesher David,Speights VO,Stankiewicz Elzbieta,Foster Christopher S,Møller Henrik,Scardino Peter,Warren Jorja D,Park Jimmy,Younus Adib,Flake Darl D,Wagner Susanne,Gutin Alexander,Lanchbury Jerry S,Stone Steven

Funder

Cancer Research UK, Queen Mary University of London, the Orchid Appeal, National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. Cancer statistics 2009;Jemal;CA Cancer J Clin,2009

2. Recent trends in prostate cancer incidence and mortality in southeast England;Evans;Eur Urol,2003

3. Screening and prostate-cancer mortality in a randomized European study;Schroder;N Engl J Med,2009

4. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyon, France;Breslow;Int J Cancer,1977

5. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20– 69: an autopsy study of 249 cases;Sakr;In Vivo,1994

Cited by 670 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing;Prostate Cancer and Prostatic Diseases;2024-09-05

2. Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy;JAMA Oncology;2024-08-22

3. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

4. A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment;Toxicological Sciences;2024-08-13

5. The omics technologies and liquid biopsies: Advantages, limitations, applications;Medicine in Omics;2024-08